Dawn Armstrong MD FRCPC
@DawnArm73326799Medical Oncologist by day, mamma/wife/dog walker always ❤️
Similar User
@stefparkerj
@FabregatFranco
@ruimmbernardino
@ericackelly
@allcancanada
@SuzDrodge
@TomOldland
@dicataldovanes1
Dr. Faour and I are already impressed with all of the promising and novel cancer treatment options for our patients #ASCO24 @OncNl @elizabethfaour
Learning how to effectively coach learners. Just like Ted Lasso, “Be a Goldfish!” Make a mistake. Learn. And move on. #ICRE2023
Advocacy is a big theme of #ICRE2023 and this was just one of the wonderful talks so far today that really focused on how we can advocate for learners as they travel through their training journey
I’m so honoured and lucky to work with such amazing women in medicine @OncNl Thank you Dr. Seal for the nomination
Congratulations Dr. Dawn Armstrong - you are CWIM's Woman of the Week!
SUNLIGHT #mCRC published @NEJM 🔥 TAS102 + bev, mOS 10.3mos We need this option in 🇨🇦 #CRCsm @coloncanada @ccranorg ➡️ nejm.org/doi/full/10.10…
Proud to have been an investigator in this trial
Thank you @JeanneTie @jonathanloree & congratulations to all DYNAMIC3 investigators & patients on reaching accrual 🙌 Another important GI trials collaboration between @GICancer @CDNCancerTrials 🇨🇦 🇦🇺 🇳🇿 🤝 #CRCsm @BCCancer
We don’t mind a Polar Vortex 🥶 We are cozy inside building consensus guidelines on the treatment of GI cancers in Eastern Canada @OncNl @AngelaHydeMDPhD
Thanksgiving on call reflections. Boy am I grateful for my healthcare family. To my fellow docs, nurses and the whole inpatient team, thank you for what you do. I’m so grateful to work alongside you.
It was a great conference for Melanoma and other Skin Cancers! Exciting to see Immunotherapy move into the neoadjuvant setting. Excellent review this morning by fellow Canadian Dr. Petrella @myESMO #ESMO22
#ESMO22: Encouraging clinical activity was reported for fruquintinib and the combination therapy of trastuzumab plus tucatinib in #mCRC 👉ow.ly/1Cfi50KGO5O
Love to see the mounting evidence for use of ctDNA in both treatment and prognosis of colorectal cancer #ESMO2022
This is super exciting! Neoadjuvant Immunotherapy for colon cancer
At #ESMO22: impressive results from the NICHE-2 trial may open a way to a ‘watch and wait’ approach for patients with #dMMR #ColonCancer 👉ow.ly/VM5y50KGkFX @JenSeligmann @MyriamChalabi
NGS can identify molecular alterations in glioma: are we ready for targeted treatments? 👇Read more about the results presented at #ESMO22 ow.ly/q5Kz50KG7KA
United States Trends
- 1. Jake Paul 1,04 Mn posts
- 2. Good Saturday 30,4 B posts
- 3. #Arcane 255 B posts
- 4. #Caturday 6.156 posts
- 5. Jayce 61,1 B posts
- 6. #SaturdayVibes 3.735 posts
- 7. Pence 85,2 B posts
- 8. #saturdaymorning 2.472 posts
- 9. Senior Day 2.544 posts
- 10. #16Nov 5.188 posts
- 11. Fetterman 39,6 B posts
- 12. IT'S GAMEDAY 3.153 posts
- 13. $XRP 91,2 B posts
- 14. $WOOPER N/A
- 15. AioonMay Limerence 164 B posts
- 16. He's 58 32,9 B posts
- 17. Vander 20,2 B posts
- 18. Woop Woop 1.493 posts
- 19. Championship Saturday 1.626 posts
- 20. maddie 24 B posts
Something went wrong.
Something went wrong.